CD79A and HIV-1 infection: Furthermore, our multivariate linear regression analysis adjusting for age as well as gender, prime-boost interval, and time after second vaccine dose reveals an effect of HIV-1 infection on serum anti-spike IgA and neutralizing antibody levels but not on anti-spike IgG levels.